Battelle
holds a direct contract to advance US biological threat reduction and
- Country
- United States
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| genome-engineering | ✓ | ✓ | ✓ |
| policy-institutions | ✓ | ✓ | ✓ |
Regulatorsfdaepa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Defense bioeconomy | policy-institutions | Medium | → |
| DNA synthesis biosecurity screening | genome-engineering | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.